Hair health study for young children and their parents
This study looks at hair samples from healthy young children and their mothers or fathers to learn more about hair biomarkers. It may help families in certain California counties who can commit to a 2-year study with check-ins every 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 6 to 24 months old and healthy.
- You or the other parent must be willing to participate too.
- You must live in Santa Clara, San Mateo, or Alameda County in Northern California.
- Your family must be willing to give your home address so study kits can be mailed to you.
- You must be able to attend follow-up visits every 6 months for 2 years.
- The child cannot have certain scalp issues, chronic health conditions, or recent steroid or other medications that affect stress hormones.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a father’s stress level over time can be estimated by measuring cortisol (a stress hormone) in hair. Results may help researchers better understand how chronic stress affects new families, especially when babies are born early or on time.
This trial tests a dietary supplement designed to reduce occasional hair shedding caused by stress, poor diet, pollution, or seasonal changes. If you've noticed more hair falling out than usual over the last few months, this study will see if the supplement helps improve your hair condition over 90 days.
This study looks at how to keep your scalp healthy after a hair transplant procedure. Researchers will test scalp management protocols to help your transplanted hair grow well and reduce dandruff-like scalp issues.
This study tests if upadacitinib can help young people with severe alopecia areata (a condition causing patchy hair loss) regrow their hair. It may be an option if hair loss has been present for less than 8 years and there has been no recent improvement.
This trial studies dupilumab (an injection medicine) to help grow hair in children and teens with alopecia areata, an autoimmune hair-loss condition. It aims to see whether the treatment improves hair regrowth compared with usual care over the study period.
This trial tests if special hair follicles can be used for cell replacement therapy in disease. It may help people with certain medical conditions.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.